TrialAsian Pacific journal of cancer prevention : APJCP2020

Neoadjuvant FOLFIRINOX followed by Chemoradiotherapy for Middle and Lower Rectal Cancer.

Amr Sakr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.